Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.55 -0.26 (-1.55%)
Streaming Delayed Price Updated: 12:46 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Chinese Growth Level
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. 
Via Talk Markets
More Chinese Trouble
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
Friday Market Coverage
New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option... 
Via Benzinga
Understanding Teva Pharmaceutical Indus's Unusual Options Activity
On Tuesday, shares of Teva Pharmaceutical Indus (NYSE:TEVA)... 
Via Benzinga
Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General... 
Via Benzinga
Tuesday Market Coverage
Thermo Electron fell on the publication of its social responsibility report today. 
Via Talk Markets
Wednesday Market Coverage
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
Via Talk Markets
Bitcoin Futures Arrive
Today you can finally hold Bitcoins via an exchange-traded fund. 
Via Talk Markets
Markets Boosted
Good news helped stock prices. 
Via Talk Markets
Perfumes Of Arabia
Downtrends do eventually run out of pessimistic steam, but it can take a while. 
Via Talk Markets
Bitcoin Is The Ferrari And Gold Is The Horse And Buggy, According To Bill Miller
Legendary value investor Bill Miller remains bullish on Bitcoin (CRYPTO: 
Via Benzinga
Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again
This company sells a migraine medicine backed by Khloe Kardashian. 
Via Investor's Business Daily
Teva Stops Production At U.S. Plant After FDA Concerns: Reports
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has temporarily stopped drug production at its Irvine plant in California to address issues raised by the FDA after... 
Via Benzinga
Exposures Product Safety
September Ends
Congress managed to pass a bipartisan short-term spending bill avoiding a crisis over the debt ceiling. 
Via Talk Markets
A Bit Of A Recovery
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week. 
Via Talk Markets
Why Teva Pharmaceutical Industries Shot Higher Today
The company reached a settlement in a legal dispute with the state of Louisiana. 
Via The Motley Fool
China's Rescue Of Evergrand
The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging. 
Via Talk Markets
Pharma, Tech and Finance
Good news on some drugs was not enough to boost stock markets. 
Via Talk Markets
Pressure Day
Today a recovery came to markets with a particular impact on uranium shares. 
Via Talk Markets
3 Smartest Big Pharma Stocks to Buy in September
You can go big this month with these three pharmaceutical stocks. 
Via The Motley Fool
A Weak Week
Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants. 
Via Talk Markets
Delta Variant Fears Continue
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher. 
Via Talk Markets
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
The FDA has accepted Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and MedinCell's marketing application seeking approval for TV-46000/mdc-IRM in... 
Via Benzinga
Exposures Product Safety
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New... 
Via Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
Friday the Thirteenth
The stock week in points eastward was mixed. The USA markets face a bear correction. 
Via Talk Markets
The Real World
The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized. 
Via Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
Delta Outbreak
The US market was droopy because of poor private sector jobless numbers. 
Via Talk Markets
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.